FindTrial
Sign In

Efficacy of Curcumin as combinatorial treatment for major depression

Efficacy of Curcumin as combinatorial treatment for major depression

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
TCTR
Registry ID
TCTR20170803002
Enrollment
Unknown
Registered
2017-08-03
Start date
2015-01-26
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

depression curcumin depression inflammation

Interventions

CURCUMIN CAPSULE,placebo capsule
Experimental Dietary Supplement,Experimental Dietary Supplement
Curcumin ( add on antidepressant),Placebo ( add on antidepressant)

Sponsors

Agricultural Research Developmental Agency ( Public Organization)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Montgomery Asberg depressive rating scale (MADRS) more than 20 scores 2. Normal CBC. EKG,BUN/Cr, Liver function test 3. Accept to participate in the study

Exclusion criteria

Exclusion criteria: 1.Pregnant women ( Negative pregnancy test) 2. No previous history of curcumin allergy

Design outcomes

Primary

MeasureTime frame
depressive scores 16 weeks Questionnaires,anxiety scores, quality of life scores 16 weeks Questionnaires—

Secondary

MeasureTime frame
Oxidative stress biomarkers baseline and after 12 week of treatment blood specimen analysis—

Countries

Thailand

Contacts

Public ContactBuranee Kanchanatawan

King Chulalongkorn Memorial Hospital

drburanee@gmail.com66891113333

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026